TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31048871

Group type: EXPERIMENTAL
Intervention: Paromomycin-gentamicin topical cream
Number of subjects: 399

Group type: COMPARATOR
Intervention: Paromomycin alone topical cream
Number of subjects: 399
Study: 27215856

Group type: EXPERIMENTAL
Intervention: Positional OSA (POSA) patients
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Non-positional OSA (NPOSA) patients
Number of subjects: 143

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 143
Study: 26695356

Group type: EXPERIMENTAL
Intervention: Multiple cleaning and disinfection interventions using antibacterial products for hand hygiene and surface cleaning or disinfection for one year
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: Multiple cleaning and disinfection interventions
Number of subjects: 393
Study: 23329889

Group type: EXPERIMENTAL
Intervention: Biodegradable conduit small gap tubulization for peripheral nerve mutilation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional epineurial neurorrhaphy
Number of subjects: 0
Study: 21953370

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stent (DES)
Number of subjects: 474

Group type: EXPERIMENTAL
Intervention: Provisional DES
Number of subjects: 474

Group type: EXPERIMENTAL
Intervention: Stent fracture rate (both DES and BMS)
Number of subjects: 474
Study: 18781486

Group type: EXPERIMENTAL
Intervention: Soy (52 g of soy protein containing 112 mg of isoflavones)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 16612397

Group type: EXPERIMENTAL
Intervention: Hemofiltration in an intensive care unit
Number of subjects: 114

Group type: COMPARATOR
Intervention: Isotonic saline hydration
Number of subjects: 114
Study: 12904084

Group type: EXPERIMENTAL
Intervention: Thalidomide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pamidronic acid and zoledronic acid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Autologous stem cell transplantation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-myeloablative transplant
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immunotherapy with dendritic cells
Number of subjects: 0
Study: 11214425

Group type: EXPERIMENTAL
Intervention: Epoetin-alpha 10,000 UI twice a week and 525 mg ferrous sulphate 3 times a day
Number of subjects: 60

Group type: COMPARATOR
Intervention: 525 mg ferrous sulphate three times a day per os for 3 weeks
Number of subjects: 60
Study: 9414541

Group type: EXPERIMENTAL
Intervention: Radical treatments (radical prostatectomy, radical radiotherapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conservative management (monitoring and treatment of symptoms)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Screening tests (DRE, PSA, TRUS, biopsy)
Number of subjects: 0
Study: 8017473

Group type: EXPERIMENTAL
Intervention: Fluvastatin 10 to 40 mg/day
Number of subjects: 381
Study: 2783678

Group type: COMPARATOR
Intervention: Oral propranolol
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Endoscopic sclerotherapy plus oral propranolol
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Transhepatic sclerotherapy plus oral propranolol
Number of subjects: 97
Study: 781848

Group type: EXPERIMENTAL
Intervention: Betamethasone dipropionate ointment; treated with active drug for three weeks
Number of subjects: 34

Group type: COMPARATOR
Intervention: Vehicle (placebo); treated with placebo for three weeks
Number of subjects: 34
Study: 31408838

Group type: EXPERIMENTAL
Intervention: Sodium nitrate (NO source)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Sodium chloride (control)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Breath-hold task
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Visual stimulation task
Number of subjects: 81
Study: 27462804

Group type: EXPERIMENTAL
Intervention: ACE-031
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25012612

Group type: EXPERIMENTAL
Intervention: Cholecalciferol (vitamin D3), 0.6 million units i.m. once
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 23819224

Group type: EXPERIMENTAL
Intervention: Comprehensive therapy (qi pathway intervention and spinal adjustment)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Conventional therapy (acupuncture and Tuina)
Number of subjects: 71
Study: 22568666

Group type: EXPERIMENTAL
Intervention: Alkaline formulation of human albumin (pH 10)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Neutral formulation of human albumin (pH 7.4)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: All injections (both formulations)
Number of subjects: 10
Study: 19125238

Group type: EXPERIMENTAL
Intervention: Zolpidem (10 mg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 17702797

Group type: EXPERIMENTAL
Intervention: Vacuum-formed retainers (VFRs)
Number of subjects: 397

Group type: COMPARATOR
Intervention: Hawley retainers
Number of subjects: 397
Study: 15138435

Group type: EXPERIMENTAL
Intervention: Nicotine gum
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo gum
Number of subjects: 20
Study: 11795346

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 11064

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11064
Study: 9369579

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 22

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 22
Study: 1565182

Group type: EXPERIMENTAL
Intervention: Erythropoietin therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2579800

Group type: COMPARATOR
Intervention: Repetitive stimulation of the wrist joint
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cessation of stimuli
Number of subjects: 0
Study: 31451436

Group type: EXPERIMENTAL
Intervention: Hypothermia and xenon
Number of subjects: 62

Group type: COMPARATOR
Intervention: Hypothermia only
Number of subjects: 62
Study: 29469011

Group type: EXPERIMENTAL
Intervention: Tongue resistance exercise and head flexion exercise against manual resistance
Number of subjects: 91

Group type: COMPARATOR
Intervention: Brochure on dysphagia rehabilitation (control group)
Number of subjects: 91
Study: 26817880

Group type: EXPERIMENTAL
Intervention: 3D-printed plates
Number of subjects: 13

Group type: COMPARATOR
Intervention: Conventional plates
Number of subjects: 13
Study: 24876611

Group type: EXPERIMENTAL
Intervention: Unmodified CGM receivers
Number of subjects: 10

Group type: COMPARATOR
Intervention: CGM receivers with numerical values obscured
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 10
Study: 22160762

Group type: EXPERIMENTAL
Intervention: Smoking cessation (quitters)
Number of subjects: 1504

Group type: COMPARATOR
Intervention: Continuing smokers (control)
Number of subjects: 1504
Study: 20847149

Group type: EXPERIMENTAL
Intervention: 12‐hr cigarette deprivation
Number of subjects: 63

Group type: COMPARATOR
Intervention: Smoking as usual (noncigarette deprivation)
Number of subjects: 63
Study: 17714375

Group type: EXPERIMENTAL
Intervention: Methylphenidate (stimulant medication)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ADHD dyads (general)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ADHD adults
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal parent-child dyads
Number of subjects: 0
Study: 15969309

Group type: EXPERIMENTAL
Intervention: Intranasal phototherapy (3 times a week for 3 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (low intensity visible light)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intranasal phototherapy
Number of subjects: 0
Study: 12028307

Group type: EXPERIMENTAL
Intervention: QLF (Quantitative Light-Induced Fluorescence)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control teeth (not exposed to demineralizing solution)
Number of subjects: 12
Study: 9809500

Group type: EXPERIMENTAL
Intervention: Intranasal budesonide aqueous suspension (256 microg once daily)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Azelastine hydrochloride nasal spray (280 microg twice daily)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 195
Study: 7695326

Group type: EXPERIMENTAL
Intervention: Fluconazole (400 mg/day)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Amphotericin B (0.5 mg/kg of body weight per day)
Number of subjects: 232
Study: 2389688

Group type: EXPERIMENTAL
Intervention: 1-minute inflations (group I)
Number of subjects: 49

Group type: COMPARATOR
Intervention: 5-minute inflations (group II)
Number of subjects: 49
Study: 7457943

Group type: EXPERIMENTAL
Intervention: Droperidol
Number of subjects: 22

Group type: COMPARATOR
Intervention: Non-Droperidol
Number of subjects: 22
Study: 31702258

Group type: EXPERIMENTAL
Intervention: Single detector optoacoustic tomography using acoustic scattering
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calibration signals from raster scanning a light-absorbing microparticle
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Regularized model-based iterative algorithm
Number of subjects: 0
Study: 28804009

Group type: EXPERIMENTAL
Intervention: Whey protein drink (30 g/120 kcal, 140 mL) consumed 3 hours before a buffet meal
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Whey protein drink (30 g/120 kcal, 140 mL) consumed 2 hours before a buffet meal
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Whey protein drink (30 g/120 kcal, 140 mL) consumed 1 hour before a buffet meal
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Whey protein drink (30 g/120 kcal, 140 mL) consumed immediately before a buffet meal
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (noncaloric drinks at all time points)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Whey protein days (total energy intake including preload + test meal)
Number of subjects: 16
Study: 25605862

Group type: EXPERIMENTAL
Intervention: Eribulin
Number of subjects: 1102

Group type: COMPARATOR
Intervention: Capecitabine
Number of subjects: 1102
Study: 23668423

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (caloric restriction and increased physical activity)
Number of subjects: 5095

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention
Number of subjects: 5095
Study: 21861961

Group type: EXPERIMENTAL
Intervention: RADPAD drape
Number of subjects: 60

Group type: COMPARATOR
Intervention: No RADPAD drape
Number of subjects: 60
Study: 18675970

Group type: EXPERIMENTAL
Intervention: Double-lumen retrieval needle
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single-lumen retrieval needle
Number of subjects: 0
Study: 17077809

Group type: EXPERIMENTAL
Intervention: Risperidone 1 mg/day
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Risperidone 4 mg/day
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Olanzapine 2.5 mg/day
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Olanzapine 15 mg/day
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Striatal D2 occupancy
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Extrastriatal D2 occupancy
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Striatal D2 blockade
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Motor side effects
Number of subjects: 14
Study: 15321026

Group type: EXPERIMENTAL
Intervention: Latanoprost once-weekly
Number of subjects: 20

Group type: COMPARATOR
Intervention: Latanoprost once-daily (control)
Number of subjects: 20
Study: 12575552

Group type: EXPERIMENTAL
Intervention: indapamide
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Lingjiao Jiangya Pill
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: amlodipine
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: benazepril
Number of subjects: 292
Study: 9197517

Group type: EXPERIMENTAL
Intervention: Antihistaminergic intervention (pheniramine)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Brainstem auditory evoked potentials (BAEPs) in Down syndrome subjects
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Auditory event-related potentials (ERPs) in Down syndrome subjects
Number of subjects: 10
Study: 8162926

Group type: EXPERIMENTAL
Intervention: CO2 (5% or 8% in O2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 100% O2
Number of subjects: 0

Group type: COMPARATOR
Intervention: Naloxone (0.8 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dexamethasone (0.1 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CO2
Number of subjects: 0
Study: 3166951

Group type: EXPERIMENTAL
Intervention: Nitrendipine at 10(‐9)M
Number of subjects: 68
Study: 31179316

Group type: EXPERIMENTAL
Intervention: Lower level of education
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Not practicing at least 30 min daily walks
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Not exercising routinely
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 204
Study: 27296456

Group type: EXPERIMENTAL
Intervention: Bilateral GON block with bupivacaine 0.5%
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham procedure with normal saline
Number of subjects: 36
Study: 26531277

Group type: EXPERIMENTAL
Intervention: Subtotal parathyroidectomy (SPTX)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Total parathyroidectomy (TPTX)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Total parathyroidectomy and autotransplantation (TPTX+AT)
Number of subjects: 63
Study: 23683134

Group type: EXPERIMENTAL
Intervention: Febuxostat 80 mg
Number of subjects: 2269

Group type: COMPARATOR
Intervention: Febuxostat 40 mg
Number of subjects: 2269

Group type: COMPARATOR
Intervention: Allopurinol (200 mg or 300 mg)
Number of subjects: 2269
Study: 20052661

Group type: EXPERIMENTAL
Intervention: Cerclage
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Cerclage for CL < or = 5.9 mm
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Cerclage for CL < or = 15.9 mm
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Cerclage for CL 16-24.9 mm
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Cerclage for CL < 25 mm
Number of subjects: 208

Group type: COMPARATOR
Intervention: No cerclage
Number of subjects: 208
Study: 17997711

Group type: EXPERIMENTAL
Intervention: Strontium ranelate 2 g/d orally for 3 years
Number of subjects: 1431
Study: 15977211

Group type: EXPERIMENTAL
Intervention: F-18 fluorodeoxy-D-glucose-positron emission tomography (FDG-PET) scanning
Number of subjects: 144
Study: 12681994

Group type: EXPERIMENTAL
Intervention: Gadolinium-enhanced MRI before and 6 weeks after catheter ablation
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (27 patients)
Number of subjects: 28
Study: 11065222

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: American Heart Association step 1 diet
Number of subjects: 30
Study: 8900554

Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 8843

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8843

Group type: EXPERIMENTAL
Intervention: Misoprostol in patients with a history of peptic ulcer disease
Number of subjects: 8843

Group type: EXPERIMENTAL
Intervention: Misoprostol in patients with a history of previous GI bleeding
Number of subjects: 8843

Group type: EXPERIMENTAL
Intervention: Misoprostol in patients with significant cardiovascular disease
Number of subjects: 8843

Group type: EXPERIMENTAL
Intervention: Misoprostol in patients with significant functional disability
Number of subjects: 8843

Group type: EXPERIMENTAL
Intervention: Misoprostol in patients requiring concomitant antacid use
Number of subjects: 8843
Study: 1800188

Group type: EXPERIMENTAL
Intervention: Celandin-aloevera-psyllium preparation
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 6409521

Group type: EXPERIMENTAL
Intervention: Phenytoin
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 31971679

Group type: EXPERIMENTAL
Intervention: Teprotumumab (10 mg/kg for the first infusion and 20 mg/kg for subsequent infusions, administered intravenously every 3 weeks for 21 weeks)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Teprotumumab
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 31516055

Group type: EXPERIMENTAL
Intervention: BKPro‐Cyan
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 30088420

Group type: EXPERIMENTAL
Intervention: Turmeric with Bioperine (n = 6)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Curcumin with Bioperine (n = 5)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (n = 3)
Number of subjects: 14
Study: 26847728

Group type: EXPERIMENTAL
Intervention: Glucose-loading at rest
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Glucose-loading following exercise
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: D-glucose (10 mmol L(-1))
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Insulin
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Oral glucose tolerance test (OGTT)
Number of subjects: 18
Study: 25707083

Group type: EXPERIMENTAL
Intervention: 35% hydrogen peroxide (HP) activated by LED/laser light
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: 35% hydrogen peroxide (HP) without LED/laser light activation
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (no restoration)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Shallow restoration
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Deep restoration
Number of subjects: 112
Study: 22431338

Group type: EXPERIMENTAL
Intervention: Riluzole at 0.5 μm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Riluzole treatment for 1 week
Number of subjects: 0
Study: 20094001

Group type: EXPERIMENTAL
Intervention: 1-page abbreviated teaching tool (ATT) summarizing CDC guidelines
Number of subjects: 237

Group type: COMPARATOR
Intervention: weblink to CDC sexually transmitted disease treatment guidelines
Number of subjects: 237
Study: 17284546

Group type: EXPERIMENTAL
Intervention: High-intensity aerobic exercise
Number of subjects: 20

Group type: COMPARATOR
Intervention: Passive modalities
Number of subjects: 20
Study: 15595937

Group type: EXPERIMENTAL
Intervention: Glatiramer acetate (GA) therapy
Number of subjects: 251

Group type: COMPARATOR
Intervention: Glatiramer acetate (GA) therapy after placebo delay
Number of subjects: 251
Study: 11875352

Group type: EXPERIMENTAL
Intervention: Informed faking (subjects given additional information about computed dynamic posturography)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Naïve subjects (no additional information provided)
Number of subjects: 60
Study: 10588611

Group type: EXPERIMENTAL
Intervention: Inhaled allergen challenge
Number of subjects: 11

Group type: COMPARATOR
Intervention: Inhaled corticosteroids pretreatment
Number of subjects: 11
Study: 7826294

Group type: EXPERIMENTAL
Intervention: Aspirin (650 mg/d)
Number of subjects: 3711

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3711
Study: 2108408

Group type: EXPERIMENTAL
Intervention: L-649,923 (oral LTD4 antagonist)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (diluent challenge)
Number of subjects: 12
Study: 6765920

Group type: EXPERIMENTAL
Intervention: Timolol (10-30 mg twice daily)
Number of subjects: 23
Study: 31368759

Group type: EXPERIMENTAL
Intervention: Extraverted behavior for 1 week
Number of subjects: 0

Group type: COMPARATOR
Intervention: Introverted behavior for 1 week
Number of subjects: 0
Study: 31297997

Group type: EXPERIMENTAL
Intervention: Microendoscope-assisted MIS-TLIF
Number of subjects: 53

Group type: COMPARATOR
Intervention: Conventional tubular retractor-assisted MIS-TLIF
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 53
Study: 28403379

Group type: EXPERIMENTAL
Intervention: Resveratrol 125 mg/d
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Resveratrol 500 mg/d
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 26044566

Group type: EXPERIMENTAL
Intervention: cilostazol 200 mg/day
Number of subjects: 1600

Group type: EXPERIMENTAL
Intervention: probucol 500 mg/day
Number of subjects: 1600

Group type: COMPARATOR
Intervention: aspirin 100 mg/day
Number of subjects: 1600

Group type: COMPARATOR
Intervention: non-probucol
Number of subjects: 1600
Study: 24007755

Group type: EXPERIMENTAL
Intervention: Keeping Baby Safe In and Around the Car DVD
Number of subjects: 195

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 195
Study: 21807446

Group type: EXPERIMENTAL
Intervention: Dyadic PFE-planning
Number of subjects: 112

Group type: COMPARATOR
Intervention: Active control conditions
Number of subjects: 112

Group type: COMPARATOR
Intervention: Negative control from partners (in control groups)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Individual action control
Number of subjects: 112

Group type: COMPARATOR
Intervention: Action control (longitudinally)
Number of subjects: 112
Study: 18757056

Group type: EXPERIMENTAL
Intervention: Pioglitazone (15 or 30mg/day)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 16781624

Group type: EXPERIMENTAL
Intervention: Engystol-based therapy
Number of subjects: 397

Group type: COMPARATOR
Intervention: Conventional therapies (antihistamines, antitussives, NSAIDs)
Number of subjects: 397
Study: 12750578

Group type: EXPERIMENTAL
Intervention: Elevated Eating Disorder Inventory (EDI) score (highest quartile)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Oligo/amenorrhea
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Eumenorrheic runners with elevated EDI scores
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Elevated EDI score and oligo/amenorrhea
Number of subjects: 91
Study: 10722768

Group type: EXPERIMENTAL
Intervention: Tiotropium 18 microg once daily
Number of subjects: 288

Group type: COMPARATOR
Intervention: Ipratropium 40 microg four times daily
Number of subjects: 288
Study: 9187981

Group type: EXPERIMENTAL
Intervention: Nurse-managed, home-based, multifactorial risk-reduction program
Number of subjects: 585

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 585
Study: 8465732

Group type: EXPERIMENTAL
Intervention: Balloon mitral valvotomy (BMV)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Surgical closed mitral valvotomy (CMV)
Number of subjects: 200
Study: 3798420

Group type: EXPERIMENTAL
Intervention: Oestrogen therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Orchidectomy
Number of subjects: 20